(p. D6) Researchers studied 1,171 patients diagnosed with advanced or metastatic colon or rectal cancer who could not be treated with surgery.
. . .
Compared with people who drank none, those who drank a cup a day had an 11 percent increased rate of overall survival, and a 5 percent increased rate of living progression-free. The more coffee they drank, the better. Those who drank four or more cups a day had a 36 percent increased rate of overall survival and a 22 percent increased rate of surviving without their disease getting worse. Whether the coffee was decaf or regular made little difference.
The study, in JAMA Oncology, controlled for race, smoking, alcohol intake, aspirin use, diabetes, and the addition of milk, nondairy creamers or sweeteners to the coffee.
For the full story, see:
(Note: ellipsis added.)
(Note: the online version of the story was updated September 23, 2020, and has the title “Drinking Coffee Tied to Better Outcomes in Colon Cancer Patients.”)
The article in JAMA Oncology mentioned above is:
Mackintosh, Christopher, Chen Yuan, Fang-Shu Ou, Sui Zhang, Donna Niedzwiecki, I-Wen Chang, Bert H. O’Neil, Brian C. Mullen, Heinz-Josef Lenz, Charles D. Blanke, Alan P. Venook, Robert J. Mayer, Charles S. Fuchs, Federico Innocenti, Andrew B. Nixon, Richard M. Goldberg, Eileen M. O’Reilly, Jeffrey A. Meyerhardt, and Kimmie Ng. “Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal Cancer.” JAMA Oncology (published online in advance of print on Sept. 17, 2020).